Glycans in Diseases and Therapeutics

Glycomedicine functions a pivotal role in cell-cell adhesion i.e. a tool utilized by cells of the immune system through sugar-binding proteins called lectins, which identify specific carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play foremost roles in numerous biological phenomena as well as in various pathophysiological processes. Many researchers have now understood that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is a significant field of research and sometimes they require a glycobiology method to be exploited.

  • Genetic disorder of glycosylations
  • Glycoprotein ligand
  • Growth factors and oncogenes
  • Genetically engineered glycan

Related Conference of Glycans in Diseases and Therapeutics

Glycans in Diseases and Therapeutics Conference Speakers